
Moderna Inc. announced Wednesday that it has launched a trial that will study the power of a redesigned booster shot — one that hones in on the highly contagious Omicron variant. The news comes just one day after Pfizer announced that it has started testing its own Omicron-specific shot. In announcing its trial, Moderna also… read on > read on >